Exploring ways we can make life better for patients taking part in clinical trials, improve access to healthcare and create better clinical outcomes, we speak to thought leaders and change makers across a range of organisations within the life sciences industry.
All content for mdtalk is the property of mdGroup and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Exploring ways we can make life better for patients taking part in clinical trials, improve access to healthcare and create better clinical outcomes, we speak to thought leaders and change makers across a range of organisations within the life sciences industry.
mdtalk LIVE | In conversation with the industry: The impact of decentralisation in clinical trials - Episode 15
mdtalk
1 hour 4 minutes 42 seconds
2 years ago
mdtalk LIVE | In conversation with the industry: The impact of decentralisation in clinical trials - Episode 15
We recently hosted a very special live podcast recording. In place of our usual mdtalk, we facilitated a live round table of experts to discuss the impact of decentralisation in clinical trials.
In this jam-packed, fascinating discussion, representatives from the patient community, sponsors, sites, and clinical operations all sat around the virtual table for the very first time to debate our common challenges:
The barriers to participation in traditional clinical trials
Why sites and sponsors might be reluctant to run a decentralised or hybrid trial, and how we can overcome these challenges
What the future looks like for the clinical trials industry
Host LaQuinta Jernigan, Chief Operating Officer at mdgroup, was joined by:
Jameka Hill - Senior Director of Clinical Trial Health Equity at Moderna
Christine Daniels - Cell Biologist at Ask Bio
Eric South - President of the Gladiator Project
Megan Liles - Vice President of Clinical Operations at ProKidney Corp
mdtalk
Exploring ways we can make life better for patients taking part in clinical trials, improve access to healthcare and create better clinical outcomes, we speak to thought leaders and change makers across a range of organisations within the life sciences industry.
